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B10.SPersistent viral infections can lead to disease such as myocarditis. Theiler's murine encephalomyelitis virus
(TMEV) infects macrophages of SJL/J (H-2s) mice establishing persistent infections leading to demyelinating
disease. In contrast macrophages from B10.S (H-2s) mice clear TMEV. Activation of the transcription factor
IRF3 induces IFNβ, ISG56, and apoptosis for viral clearance, but also inﬂammatory cytokines, such as IL-23 and
IL6, which contribute to disease. Here we identify polymorphisms in the IRF3 of SJL/J versus B10.S mice that
are located in DNA binding, nuclear localization, and autoinhibitory domains. SJL-IRF3 expression in
RAW264.7 macrophage cells with or without TMEV infection decreased IL-23p19 promoter activity compared
with B10S-IRF3. In contrast SJL-IRF3 increased IL-6, ISG56 and IFNβ in response to TMEV. B10S-IRF3
expression augmented apoptotic caspase activation and decreased viral RNA in TMEV-infected macrophages
while SJL-IRF3 increased viral replication with less caspase activation. Therefore IRF3 polymorphisms
contribute to viral persistence and altered cytokine expression.iv. of Nebraska Med. Ctr., 40th
1 402 472 2551.
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Humans become infected by viruses throughout life. After the
acute stage of each infection, viruses are controlled by the innate and
adaptive immune systems either by eliminating the viruses and virus
infected cells entirely or by tolerating a persistent lifelong infection
(Virgin et al., 2009). The bases for persistent viral infections are
unclear, but virus interference with host cytokine production and
apoptosis is thought to play a role. Macrophages are essential to anti-
viral immunity because they destroy phagocytized viruses and
produce cytokines that inﬂuence innate and adaptive immune
responses. Cytokine production is induced when viral nucleic acids
in the late endosome bind to pattern recognition receptors (PRRs),
activate cell signaling pathways and transcription factors for cytokine
responses. For instance, Toll-like receptor (TLR)-3 recognition of viral
dsRNA (Diebold et al., 2004; Heil et al., 2003; Latz et al., 2004) leads to
activation of the IRF3 transcription factor (Horng et al., 2002; Takeuchi
et al., 2004). However, macrophages are sometimes infected by viruses.
Cytokine production can occur if macrophages are infectedwith viruses
when cytoplasmic helicases recognize viral RNA. Retinoic Acid Induciblegene-I (RIG-I) recognizes uncapped 5′-triphosphorylated-RNA that is
unique to viruses (Hornung et al., 2006; Pichlmair et al., 2006) and
melanoma differentiation-associated gene (MDA)-5 recognizes RNA
from picornaviruses that are triphosphorylated and capped with viral
protein (VPg) (Kato et al., 2006; Yoneyama et al., 2005). Activation of
either RIG-I and MDA5 pathways via mitochondrial (Kawai et al.,
2005;,Seth et al., 2005) and peroxisomal (Dixit et al., 2010) MAVS (also
known as IPS-1, CARDIF, VISA) also leads to activation of IRF3. As a result
of IRF3 activation, IFNβ, IL-6, and interferon stimulated genes (ISG) such
as ISG56 are expressed. We also found that IRF3 represses IL-12 p35
(Dahlberg et al., 2006) and induces IL-23 p19 expression from
macrophages challenged with Theiler's Murine Encephalomyelitis
Virus (TMEV). Therefore, activation of IRF3 is a common feature of
macrophage anti-viral responses following both phagocytosis of and
infection by viruses in order to achieve the correct cytokine and anti-
viral factors for innate and adaptive immunity.
In addition to its role in geneexpression, IRF3 is also involved in virus
induced apoptosis in cells infected by viruses (Heylbroeck et al., 2000).
IRF3 activation induces proapoptotic caspase-3, 8, 9 activities. Induction
of apoptosis is dependent on IRF3 interactionwithBax at aa366-427, the
apoptosis activation domain (AAD)of IRF3 (Chattopadhyay et al., 2010).
Following interaction of IRF3-AAD with Bax, the Bax/IRF3 dimer
translocates tomitochondria causing release of cytochromeC, activation
of the apoptosome and caspase 9, followed by activation of caspase 3. It
is thought that induction of apoptosis in virus infected cells limits the
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persistence (Chattopadhyay et al., 2011).
IRF3 is constitutively expressed in macrophages, is autoinhibited by
two unphosphorylated inhibitory domains (ID), and is activated via
hyperphosphorylation of the IDs. Activated TBK1/IKKε phosphorylates
carboxy terminus serine/threonines of IRF3 positioned between aa385
and 405 at one of the inhibitory domains (ID1) (Fig. 1A). In addition,
activated JNK-MAPK phosphorylates serine-173 of IRF3, which is near
the other ID (ID2) and nuclear export a signal (NES) domain (Zhang
et al., 2009). These phosphorylations rearrange the IDs and permit
dimerization with IRFs at the IRF association domain (IAD), nuclear
entry, interactionwith the CBP/p300 transcription factor (Weaver et al.,
1998), and binding to promoter elements via the N-terminal DNA
binding domain (DBD). Promoters responsive to IRF3 after viral
infection of cells include the IFNβ (Panne, 2008), IL-6 (Sweeney et al.,
2010) and ISG56 (Grandvaux et al., 2002) genes. Therefore, activation of
IRF3 is critical to the immediate/early response of macrophages to virus
infection through expression of cytokines and ISGs, as well as induction
of apoptosis. Because the humanpopulation has several polymorphisms
at the IRF3 locus (rs79173361, rs2230667, rs968457, rs7251) that
change single amino acids near the DBD and ID1 it is imperative to
understand how polymorphisms at these IRF3 domains change the
responses of macrophages to viruses.
Theiler's murine encephalomyelitis virus (TMEV) persistently in-
fects and causes Multiple Sclerosis-like neuroinﬂammatory disease inA
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Fig. 1. Comparison of the predicted amino acid sequences of IRF3 from B10.S and IRF3 from
Localization Signal (NLS), Autoinhibitory Domain (ID) 1 and 2, Nuclear Export Signal (NES
Domain (SRD) and the sites phosphorylated by JNK and TBK/IKKε. The 33R(B10.S)NG(SJL/J)
acid sequence with B10.S IRF3 amino acid sequence. Following extraction from agarose an
predicted amino acid sequence was generated. The DNA binding domain (__), the autoinhibSJL/J mice (H-2s) but not B10.S mice (H-2s) (Aubagnac et al., 2002;
Monteyne et al., 1999; Vigneau et al., 2003). Thus comparison of TMEV
induced responses in SJL mice with those of B10.S mice identiﬁes non-
MHC genes that are involved in persistent viral infections that lead to
disease. One of the differences between these two strains is TMEV's
chronic infection of macrophages that inﬁltrate the white matter of the
CNS in SJL/J but not B10.S mice. We have found that the cellular and
electrophoretic activities of IRF3 from SJL/J macrophages are distinctly
different than that of IRF3 in B10.Smacrophages (Dahlberg et al., 2006).
This is signiﬁcant because viral replication in infected macrophages is
higher, survival of infected macrophages is greater, macrophage
expression of IL-12 is lower, and IFNβ expression is higher during
innate anti-TMEV immune responses of SJL/J macrophages compared
with B10.S macrophages (Petro, 2005a). We have previously seen that
the IL-23 p19 promoter in RAW264.7 cells is activated following
challenge with TMEV (Al-Salleeh and Petro, 2007). These data suggest
that IRF3 polymorphisms could be the bases for the different
phenotypes of SJL/J and B10.S macrophage responses to TMEV. The
present study extends the analysis of these differences in IRF3 by
comparing the aminoacid sequences, theTMEV-induced transcriptional
activities, and the TMEV-induced apoptotic activities of IRF3 from SJL/J
and B10.S mice. IRF3 from SJL/J mice is different than that from B10.S
mice in that there are three single nucleotide polymorphisms that
predict three amino acid differences in the protein. RAW264.7
macrophage cells overexpressing IRF3 from SJL/J mice expressed more50
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), IRF association domain (IAD), Apoptosis Activation Domain (AAD), Signal Response
, 147INV, and the 169QNR polymorphisms are noted. B. Alignment of SJL/J IRF3 amino
d cloning into pTARGET expression vector, the inserted cDNA was sequenced and the
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expressing B10.S IRF3. Therefore, TMEV RNA was higher in RAW cells
expressing SJL/J IRF3 following challenge with TMEV compared to cells
expressing B10.S IRF-3. In contrast, RAW cells with B10.S IRF3 exhibited
signiﬁcantly greater active caspase-3/7 compared with cells expressing
SJL/J IRF3, suggesting greater virus-induced apoptosis. Therefore, IRF3 is
a signiﬁcant factor in the differential response of SJL/J and B10.S mice to
infection with TMEV.
Results
IRF3 from SJL/J mice has three amino acid polymorphisms compared
with IRF3 from B10.S mice
IRF3 from SJL/J mice exhibits atypical activity in macrophages
compared with IRF3 from B10.S mice (Dahlberg et al., 2006). Because
SJL/J and B10.S mice have distinct genealogical origins (Beck et al., 2000)
polymorphisms are likely to exist between the two strains. To determine
if differences in IRF3 exist between SJL/J and B10.S mice, IRF3 cDNA from
macrophages of each strain was ampliﬁed by PCR using 5′ sense and 3′
anti-sense primers corresponding to the published mouse IRF3 coding
sequence (NM_016849). The approximately 1200 base pair PCR products
from each cDNA were inserted into the pTARGET expression vector to
yield pSJL-IRF3 and pB10S-IRF3. The insert sequence of pB10S-IRF3 was
identical to the published mouse IRF3 coding sequence (NM_016849)
(Fig. 1). However, the inserted pSJL-IRF3 sequence contains a G rather
than an A at nt position 97 that predicts an arginine(R)Nglycine (G) at aa
33, a G rather than an A at nt position 439 that predicts an isoleucine (I)N
valine (V) change at aa 147, and a G rather than an A at nt position 503
that predicts a glutamine (Q)Narginine (R) change at aa 169 (Fig. 1). The
R33G is locatedwithin the DBD of IRF3, the I147V is near the NLS, and the
Q169R is in the ID1 autoinhibitory domain, near the CBP/p300 interacting
domain (Weaver et al., 1998), nuclear export signal (NES), and the serine-
173 that is phosphorylated by JNK-MAP-kinases following viral infection
(Zhang et al., 2009). Therefore the SJL/J IRF3 has three SNP poly-
morphisms that could inﬂuence its activity.
IRF3 is constitutively expressed in an inactive form in macro-
phages (Servant et al., 2002). After viral challenge of macrophages
IRF3 becomes active after post-translational hyperphosphorylation in
a sequence of reactions at its carboxy terminal signal response and
middle inhibitory domains. To initially evaluate SJL versus B10S IRF3,
SJL-IRF3 pTARGET and B10S-IRF3 pTARGET expression vectors were
transfected into RAW264.7 cells, a macrophage cell line, which were
then left unchallenged or challenged with TMEV. After 9 h, cell lysates
were western immunoblotted for IRF3 and tubulin production.
Unchallenged RAW cells expressing SJL-IRF3 and B10S-IRF3 produced
equivalent levels of IRF3 protein (Fig. 2A). This was conﬁrmed with
quantitative real-time PCR (data not shown). TMEV-challenged RAW
cells expressing B10S-IRF3 exhibited a small increase in hyperpho-
sphorylated IRF3 after 9 h. In contrast, TMEV-challenged RAW cells
with SJL-IRF3 exhibited a much larger increase in hyperphosphory-
lated IRF3, as evidenced by its mobility shift. Therefore, IRF3 in RAW
cells with SJL-IRF3 exhibits enhanced post-translational phosphory-
lation following TMEV challenge.
SJL/J IRF3 does not induce or enhance IL-23 p19 promoter activity as well
as B10.S IRF3
Using a reporter vector that contains the mouse IL-23 p19 promoter
(Petro, 2005b), we have shown that IL-23 p19 expression in RAW cells
after TMEV challenge peaks at 24 h and IRF3 is involved in IL-23 p19
promoter activity due to a potential IRF3 binding element (Al-Salleeh and
Petro, 2008). To compare transcriptional activity of SJL-IRF3 with B10S-
IRF3, we transfected each expression vector along with the IL-23 p19
promoter-reporter vector (p19prompGL3) into RAW cells. Transfection
efﬁciencies were approximately 50% based upon expression of GFP fromparallel transfections with pmaxGFP, which constitutively expresses GFP.
Transfection of pB10S-IRF3 increased p19 promoter activity signiﬁcantly
more than empty vector (Fig. 2B). In contrast pSJL-IRF3 signiﬁcantly
decreased p19 promoter activity comparedwith cells with empty vector.
Transfection of either pSJL-IRF3 or pB10S-IRF3 signiﬁcantly increased p19
promoter activity following challenge of RAW cells with TMEV (Fig. 2C).
However, enhancement of p19 promoter activity due to challenge with
TMEV was signiﬁcantly greater in RAW cells with pB10S-IRF3 compared
with pSJL-IRF3. Therefore transcriptional activity of SJL-IRF3 for the IL-23
p19 promoter is signiﬁcantly different than B10S-IRF3.
SJL/J IRF3 augments IFNβ, ISG56, and IL-6 expression but also TMEV RNA
replication during TMEV infection of RAW cells
In addition to IL-23p19,wehave seen that challenge ofmacrophages
with TMEV induces expression of IFNβ (Petro, 2005b) and IFNβ
expression was greater in macrophages from SJL/J mice infected with
TMEV compared with B10.S macrophages (Dahlberg et al., 2006). To
determine if the dichotomy in IRF3 between SJL/J and B10.S mice could
be responsible for these conﬂicting results, we transfected pSJL-IRF3,
pB10S-IRF3, or control vector into RAW cells, challenged transfected
cellswithTMEV, and thendetermined IFNβ expression by qRT-PCRafter
9 h. Expression of IFNβ was signiﬁcantly greater in TMEV-challenged
RAW264.7 cells with pSJL-IRF3 compared with those with pB10S-IRF3
or control vector (Fig. 3A). Therefore, SJL-IRF3 promotes increased IFNβ
expression in macrophages.
In addition to IRF3, several other transcription factors cooperatewith
IRF3 at the IFNβ enhanceosome (Panne et al., 2007). In contrast, ISG56
expression in response to viral infection of cells takes place with IRF3
activation independent of other factors (Grandvaux et al., 2002). We
compared ISG56 expression in RAW cells transfected with pSJL-IRF3,
pB10S-IRF3, or control vector 9 h after challenge with TMEV. Similar to
IFNβ, expression of ISG56was signiﬁcantly greater in TMEV-challenged
RAW cells with SJL-IRF3 compared with those with pB10S-IRF3 or
control vector (Fig. 3B).
Recently, it was shown that SJL/J mice infected with TMEV are
susceptible to neuroinﬂammatory autoimmune disease due in part to
high IL-6 expression by TMEV infected SJL/J APCs, whichwas not seen in
TMEV-resistant C57Bl/6 mice (Hou et al., 2009). Recent data suggests
that IRF3 plays an important role in expression of IL-6 in inﬂammatory
disease (Sweeney et al., 2010). To compare the inﬂuence of SJL-IRF3 and
B10S-IRF3 on this cytokine, we quantiﬁed IL-6 expression in RAW cells
transfected with pSJL-IRF3, pB10S-IRF3, or empty vector 9 h after
challenge with TMEV. Expression of IL-6 was signiﬁcantly greater in
TMEV-challenged RAW cells transfected with pSJL-IRF3 comparedwith
those with pB10S-IRF3 or empty vector (Fig. 3C). These data indicate
that SJL/J-IRF3 could play a role in the enhanced susceptibility of SJL/J
mice to TMEV-induced neuroinﬂammatory autoimmune disease.
TMEV replication is greater in SJL/J macrophages than in B10.S
macrophages (Petro, 2005b). Similarly replication of TMEV RNA is
signiﬁcantly greater in TMEV-infected RAW cells with pSJL-IRF3
compared with cells with empty vector or pB10S-IRF3 (Fig. 3D). In
addition, RAW cells with pB10S-IRF3 exhibited signiﬁcantly less TMEV
RNA than RAW cells with empty vector. Therefore, B10S-IRF3 leads to
decreased while SJL-IRF3 leads to increased TMEV RNA production in
macrophages.
RAW cells with SJL/J IRF3 have lower ISG56 and IL-6 in response to
polyIC
In order to activate IRF3 for IFNβ and ISG56 expressionmacrophages
that encounter RNA-viruses like TMEV use TLR3 to sense viral RNA
during phagocytosis of virus (Al-Salleeh and Petro, 2007) but use
cytoplasmic RIG-1 and MDA5 to sense viral RNA during infection with
virus (Pichlmair et al., 2006).We next wanted to compare the effects of
SJL-IRF3 with B10S-IRF3 on IL-6, IFNβ, and ISG56 expression during
Fig. 2. IRF3 protein and IL-23 p19 promoter activity in RAW cells expressing polymorphic IRF3. A. Western blot of IRF3 and tubulin in RAW cells following nucleofection with pCIneo
(empty vector), SJLIRF3pTARGET or B10SIRF3pTARGET. Transfected RAW264.7 cells were left uninfected or infected with 3×105 TMEV PFU. Nine h after infection cells were lysed and
10 ug of protein immunoblotted. Numerical values are ratios of the sum of the densitometric values of three IRF3 bands divided by the densitometric value of the tubulin band. B, C.
IL-23 p19 promoter activity in 3×105 RAW264.7 cells incubated overnight, were co-transfected with pCIneo (empty vector), SJLIRF3pTARGET or B10SIRF3pTARGET plus p19prompGL3
and pRL-SV40 vectors. Transfected RAW264.7 cells were left uninfected or infected with 3×105 TMEV PFU. Promoter activity in cells was measured as ﬁreﬂy luciferase-dependent
luminescence expressed from p19prompGL3 normalized to renilla luciferase-dependent luminescence expressed from pRL-SV40 in 24-h cell extracts divided by ratios obtained
from uninfected cells. Data are means of 5 samples each of a representative experiment±standard error; * indicates that the mean fold increase in promoter activity in uninfected
cells with SJLIRF3pTARGET (pSJL-IRF3) or B10SIRF3pTARGET (pB10S-IRF3) is signiﬁcantly different than the promoter activity in uninfected cells with pCIneo control. Brackets indicate
signiﬁcant differences promoter activity in TMEV infected cells.
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pB10S-IRF3, or control vector. Twenty four h after transfection cells
were stimulatedwith the TLR3 agonist, polyIC, whichwill not stimulate
RIG-I/MDA5 pathways unless transfected into the cytoplasm (Diebold
et al., 2003; Yoneyama et al., 2005) orwill not stimulate IFNβ expression
in TLR3 knockdown RAW cells (Al-Salleeh and Petro, 2007). In contrast
to the response to TMEV challenge, neither SJL-IRF3 nor B10S-IRF3
signiﬁcantly inﬂuenced expression of IFNβ in response to polyIC at 9 h
(Fig. 4A). However, pSJL-IRF3 signiﬁcantly decreased IL-6 (Fig. 4B) and
ISG56 (Fig. 4C) expression in response to polyIC compared with pB10S-
IRF3 or control vector. These data suggest that the increased expression
of IL-6, IFNβ, and ISG56 during the TMEV infection ofmacrophageswith
SJL-IRF3 is not dependent upon TMEV stimulation of the TLR3 pathway.
TMEV-induced caspase 3 activation and Bax levels are lower in RAW
cells with SJL/J IRF3
In addition to its role in gene expression, virus-induced IRF3 activation
induces proapoptotic caspase-3, 8, 9 activities (Heylbroeck et al., 2000)
indicating a role for this protein in virus-induced apoptosis.Wehave seen
that SJL/Jmacrophages infectedwith TMEVaremore viable after infection
compared with B10.S macrophages (Dahlberg et al., 2006). To determineif the SJL-IRF3 polymorphisms hinder virus-induced caspase-3/7 activa-
tion in TMEV-infected macrophages, RAW264.7 cells were transfected
with pSJL-IRF3, pB10S-IRF3, or control vector before challenge with
TMEV. Caspase 3/7 activity in cells was quantiﬁed by measuring amino-
luciferin release from a substrate containing Z-DEVD-Luciferin using a
luciferase assay. Following TMEV infection caspase 3/7 activity was
greater in RAW cells expressing B10S-IRF3 at 16 (Fig. 5A) and 35 h
(Fig. 5B) PI compared with uninfected RAW cells with B10S-IRF3 or
infected RAW cells with SJL-IRF3. Therefore, SJL-IRF3 diminishes TMEV-
induced caspase activation compared with B10S-IRF3 due its poly-
morphisms. Bax is a proapoptotic 21 kDa cellular protein which can
homo- or heterodimerize with BH3-domain containing proteins, includ-
ing IRF3, to induce mitochondria-associated apoptosis (Chattopadhyay
et al., 2010;Chattopadhyayet al., 2011). To conﬁrm, the impactof SJL-IRF3
on virus induced apoptosis, Bax protein was evaluated by immunoblot
followed by densitometry. Immunoreactive Bax protein was detected at
approximately 75 kDa, indicating its multimerization with other BH3-
containing proteins. Following TMEV infection relative Bax levels
increased more in RAW cells overexpressing B10S-IRF3 than in RAW
cells overexpressing SJL-IRF3 or non-transfected RAW cells (Fig. 5C, D).
Therefore TMEV-induced Bax-associated apoptosis is likely diminished in
macrophages with polymorphic SJL-IRF3.
Fig. 3. Effect of SJL-IRF3 and B10.S IRF3 on relative expression of IFNβ, IL-6, ISG56, and TMEV RNA after TMEV infection. Real-time PCR of IFNβ (A), ISG56 (B), IL-6 (C), and TMEV RNA
(D) in uninfected or TMEV-infected RAW264.7 cells transfected with pCIneo (control), SJLIRF3pTARGET (SJL), B10SIRF3pTARGET (B10.S) as measured after 9 h. Levels of IFNβ, IL-6,
ISG56, and TMEV RNA relative to GAPDH RNA were evaluated by real-time PCR. Individual means were evaluated with the Wilcoxon-Mann–Whitney rank-sum U test. Comparisons
of means in which P valuesb0.05 are bracketed. *Pb0.05, **Pb0.01. Data are an average+standard error of 3 replicates per group and two different experiments.
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Chronic viral infection is a commonhumancondition that oftentimes
leads to disease in the infected host beyond that which is seen with the
initial infection. Like humans, mice experience chronic viral infections
that sometimes lead to disease. Strains of TMEV infectmost feralmice at
some point in their natural life, but it was noticed about 75 years ago
that the SJL/J laboratory mouse strain that becomes infectedwith TMEV
develops a chronic infection followed by a demyelinating disease
(Theiler, 1937). Several studies set out to determine the basis for
susceptibility to TMEV-induced demyelinating disease (Bihl et al., 1999;
Vigneau et al., 2003) by comparing susceptible SJL/J (H-2s) with B10.S
(H-2s)mice, the latter being resistant to persistent TMEV infection. This
approach permitted the discovery of non-MHC chromosome regions
responsible for differential susceptibility to TMEV. These studies have
revealed that the telomeric end of Chromosome 10 in mice in a region
that is near the IFNγ and IL-22 genes predisposes SJL/J mice to greater
susceptibility to chronic TMEV infection in macrophage lineage cells.
However, no protein product of a gene was deﬁnitively identiﬁed from
these studies for viral persistence in SJL/J macrophages. Our previous
studies comparing SJL/J and B10.S macrophage responses to TMEV
showed that the cellular localizations of IRF3 in macrophages and the
electorphoretic mobilities of IRF3 differ between these two strains of
mice (Dahlberg et al., 2006). The present study conﬁrms that SJL/J and
B10.S IRF3 are different between these two mouse strains and these
differences confer greater susceptibility of SJL/J macrophages to
persistent infection with TMEV. We show here that the SJL-IRF3 gene
has three single nucleotide polymorphisms that are predicted to lead tothree amino acid differences compared with B10-IRF3. One of the
polymorphisms R33G is located in theDNA binding domain of IRF3 near
the amino acidsW38 and L42, R43, andQ44which are known to contact
DNA elements of the IFNβ enhancesome (Panne et al., 2007). It remains
to be seen if the R33G alters the ability of IRF3 to physically bind to
promoter elements for either enhancement or repression of gene
expression. However, in the present study, overexpression of SJL-IRF3,
unlike B10S-IRF3, failed to induce IL-23 p19 promoter activity and
exhibited signiﬁcantly impaired ability to enhance IL-23 p19 promoter
activity during TMEV infection of RAW cells. The IL-23 p19 promoter,
which contains a putative IRF3 binding element, was activated by
overexpression of B10S-IRF3, but not by SJL-IRF3, even without TMEV
infection. So far the R33G polymorphism has not been found in other
strains of mice. However, a human polymorphism in IRF3 in which
glutamine at aa 48 is changed to glutamic acid is found in 2% of west
African population samples tested (rs76863988) would be expected to
inﬂuence the DBD.
These data suggest that SJL/J macrophages by virtue of their
polymorphic IRF3 should exhibit depressed IL-23 p19 expression
following TMEV challenge compared with B10.S macrophages. Howev-
er, CD4+ T cells from TMEV-susceptible SJL/J mice develop more Th17
compared to CD4+ T cells from TMEV-resistant C56Bl/6 mice following
challenge with TMEV. Because of the involvement of IL-23 in Th17
development, this would imply that SJL/J macrophages might express
higher levels of IL-23. We have indeed shown previously that SJL/J
macrophages do express IL-23 p19 mRNA and produce IL-23 protein
during TMEV infection (Al-Salleeh and Petro, 2008).While IL-23 has been
linked to Th17, its role is to sustain the Th17 phenotype following Th17
Fig. 4. Effect of SJL-IRF3 and B10.S IRF3 on relative expression of IFNβ, ISG56, and IL-6
after polyIC stimulation. Real-time PCR of IFNβ (A), ISG56 (B), and IL-6 (C) in RAW264.7
cells transfected with pCIneo (control), SJLIRF3pTARGET (SJL), B10SIRF3pTARGET (B10.S)
as measured after 9 h. Levels of IFNβ, IL-6, and ISG56 RNA relative to GAPDH RNA
were evaluated by real-time PCR. Individualmeanswere evaluatedwith the Student's t test.
Comparisons of means in which P valuesb0.05 are bracketed with a *. Data are an
average+/−standard error of 3 replicates per group from a representative experiment.
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(2009) have shown that enhanced Th17 by SJL/J mice during TMEV
infection is due to increased IL-6 and not IL-23 expression. Furthermore
we have shown that knockdown of IRF3 with RNAi approaches did not
alter TMEV-induced IL-23p19 (Al-Salleeh andPetro, 2008) and therewas
little impact on IL-23 p19 expression in IRF3 knockout mice (Johnson
et al., 2011). Altogether these results suggest that in the presence of IRF3
IL-23 p19 expression increases but in its absence its expression is
unaffected. This may be due to the fact that IL-23 p19 expression in
response to TMEV, unlike IRF3, is totally dependent on other transcrip-tion factors such as ATF2, SMAD3, and NF-κB at the IL-23 p19 promoter
(Al-Salleeh and Petro, 2008).
In contrast to IL-23 p19, expressions of IFNβ, ISG56, and IL-6, all of
which are known to be dependent upon IRF3, were enhanced during
TMEV infection of macrophages when SJL-IRF3 was overexpressed.
Therefore, the transcriptional effect of the SJL/J polymorphic IRF3 is
not the same for each IRF3 responsive gene. This may be due to the
fact that IRF3 collaborates with other transcription factors such as
IRF7, ATF2, NF-κB, and c-Jun at the IFNβ enhancesome, with ATF2,
SMAD3, and NF-κB at the IL-23 p19 promoter (Al-Salleeh and Petro,
2008), but can induce promoter activity at the ISG56 gene
independent of other transcription factors (Grandvaux et al., 2002).
Paradoxically we found here TMEV replication is increased in cells
with higher IFNβ and ISG56 expression. These results are similar to
our previous ﬁnding comparing TMEV-infected SJL/J macrophagewith
B10.S macrophages (Petro, 2005a). In that report TMEV replication
and IFNβ expression was higher in SJL/J macrophages than in B10.S
macrophages. IRF3-induced ISG56 was originally thought to have
anti-viral activity. Its enhanced expression in RAW264.7 cells with
SJL-IRF3 would be expected to decrease TMEV RNA replication.
However, enhanced ISG56 expression in these cells was accompanied
by increased TMEV RNA replication. More recently ISG56 was shown
to also regulate anti-viral responses, inhibit cellular protein synthesis,
and even enhance viral replication (Li et al., 2009; Stawowczyk et al.,
2011). Therefore, augmentation of ISG56 by IRF3 may dampen or
negate some of the other anti-viral effects initiated by IRF3. Moreover,
Hou et al. (2009) showed that TMEV-induced pathogenesis in SJL/J
mice is related to heightened IL-6 expression despite an elevated IFNβ
response. We show here that the polymorphic IRF3 of SJL/J mice may
be related to the TMEV-induced pathogenesis in SJL/J mice due to its
ability to increase the expression of IL-6 and perhaps ISG56.
Another IRF3 polymorphism described here, 169QNR, is located in
a region that is part of the ﬁrst ID, which with the second ID results in
IRF3 latency (Takahasi et al., 2003). Hyperphosphorylation of serines
and threonines in the second ID by TBK/IKKε and phosphorylation of
serine-173 in the ﬁrst ID by JNK-MAPK (Zhang et al., 2009) results in
rearrangement of the IDs, IRF3 dimerization, and nuclear localization.
It is possible that the proximity of 169QNR to serine-173 affects the
ﬁrst ID resulting in rearranged IRF3 with a different electrophoretic
mobility and constitutive nuclear localization previously reported
(Dahlberg et al., 2006). Earlier nuclear localization could also explain
the heightened expression of IFNβ, ISG56, and IL-6 observed here
during macrophage responses to TMEV with SJL-IRF3. It should be
noted that this polymorphism in SJL/J mice has been conﬁrmed
(rs37133231), is also present in other strains such as NZW and BPL/1J
but is absent in B10, C57Bl/6, and Balb/c mice. It remains to be seen if
these other strains of mice with the same IRF3 polymorphism exhibit
similar responses to viral infection.
The results presented herein suggest that the IRF3 polymorphisms
are responsible for several phenotypes during TMEV infection in SJL/J
macrophages that do not occur in B10.S macrophages. Our previous
results showed that macrophages from SJL/J mice expressed more
IFNβ before and following infection with TMEV than macrophages
from B10.S mice. The present investigation shows that RAW cells
overexpressing either SJL-IRF3 or B10S-IRF3 exhibit the same
dichotomy in IFNβ phenotype following TMEV infection. Interestingly,
in our previous studies (Dahlberg et al., 2006; Petro, 2005a) enhanced
IFNβ expression was not seen when SJL/J macrophages were
stimulated with polyIC, which will stimulate IFNβ through TLR3 but
will not stimulate IFNβ through RIG-I/MDA5 pathways unless
transfected into the cytoplasm (Diebold et al., 2003; Yoneyama
et al., 2005). We have shown that RAW cells with knocked down TLR3
expressionwill not express IFNβ in response to polyIC (Al-Salleeh and
Petro, 2007). Here, polyIC induced expression of IFNβ, ISG56, and IL-6
but RAW cells expressing SJL-IRF3 did not exhibit higher expression of
these factors in response to polyIC compared with RAW cells with
Fig. 5. Effect of SJL-IRF3 and B10.S IRF3 on virus induced caspase activation and Bax protein. Caspase activation after 16 h (A) and 35 h (B) in uninfected or TMEV-infected RAW264.7
cells transfected with pCIneo (control), SJLIRF3pTARGET (SJL), B10SIRF3pTARGET (B10.S). Levels of caspase activation were evaluated by the release of luciferin from Z-DEVD-
luciferin substrate and then measuring luminescence by adding UltraGlo™ luciferase from Promega. Individual means of 5 samples each of a representative experiment were
evaluated with the Student's t test. Comparisons of means in which P valuesb0.05 are bracketed. Data are an average±standard error of 3 replicates per group from a representative
experiment. (C) Western blots of Bax and beta-tubulin protein in uninfected or TMEV-infected RAW264.7 cells transfected with pCIneo (Control), SJLIRF3pTARGET (SJL), or
B10SIRF3pTARGET (B10.S). (D) Densitometric ratio of Bax in 9 h TMEV-infected RAW cells with pCIneo (Control), SJLIRF3pTARGET (SJL-IRF3), or B10SIRF3pTARGET (B10.S-IRF3) with
Bax uninfected RAW cells with pCIneo, SJLIRF3pTARGET, or B10SIRF3pTARGET, respectively.
46 T.C. Moore et al. / Virology 418 (2011) 40–48B10S-IRF3. The IFNβ response of macrophages challenged with TMEV
is in part dependent upon TLR3 (Al-Salleeh and Petro, 2007; So et al.,
2006). TLR3 pathways are activated by viral RNA or polyIC in the late
endosome in which downstream TRIF activation leads to activation of
TBK1/IKKε and then IRF3. The results here suggest that even though
polyIC stimulates IFNβ expression through the TLR3 pathway the
enhancement of IFNβ expression due to polymorphic SJL-IRF3 are not
dependent on the TLR3 pathway.
While IRF3 plays an important role in cytokine and ISG expression
following virus infection ofmacrophages it also has an important role in
induction of virus induced apoptosis (Sharif-Askari et al., 2007).
Activated IRF3 associates with Bax and localizes to mitochondria, thus
inducing cytochrome C release into the cytoplasm ultimately leading to
caspase activation (Chattopadhyay et al., 2010). Hou et al. (2009)
showed that SJL/J macrophages infected with TMEV exhibit decreased
virus-induced Annexin V, which is expressed by cells during apoptosis.
We have seen that survival of SJL/J macrophages following TMEV
infection is greater than that of TMEV-infected B10.S macrophages
(Dahlberg et al., 2006). These data raise the possibility that TMEV-
induced apoptosis is diminished in SJL/J macrophages. We show herein
for the ﬁrst time that expression of SJL-IRF3 in RAW cells during TMEVinfection led to signiﬁcantly decreased caspase activation, another
characteristic of apoptosis, compared with caspase activation in cells
with B10S-IRF3. Similarly expression of the proapoptotic Bax protein
was lower in cells expressing SJL-IRF3 compared with B10S-IRF3.
Interestingly we found that Bax protein in RAW cells forms a 75 kDa
hetero- or homo-multimer complex with other proteins most likely
containing theBH3associationdomain. It remains tobe seen if this is the
native endogenous conﬁguration of Baxmultimers in RAW cells or is an
artifact of western blot. Previous studies have shown that detergents in
western blot lysing buffers stabilize or enhance formation of Bax
multimers even under denaturing condition (Hsu and Youle, 1997,
1998). Nevertheless, these data indicate that not only does the
polymorphic IRF3 of SJL/J mice play a role in cytokine phenotype
following TMEV infection but it also is deﬁcient in inducing apoptosis in
TMEV-infected macrophages. Since virus-induced apoptosis reduces
viral replication and persistence (Peters et al., 2008; Chattopadhyay
et al., 2011), these data suggest that polymorphisms in SJL-IRF3 may
decrease virus-induced apoptosis leading to increased virus replication
and persistence.
It is noteworthy that chronic TMEV infection of SJL/J mice leads to
demyelinating disease similar to human Multiple Sclerosis (MS).
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human chromosome region 19q13 (Bonetti et al., 2009; Haines et al.,
2002). Interestingly, the human IRF3 gene is located at chromosome
region 19q13. However, it will take additional investigations to
determine if one or more of the human IRF3 polymorphisms
(rs79173361, rs2230667, rs968457, rs7251) are bases for the MS
susceptibility locus at 19q13. In summary, the results of this report
clearly show that the IRF3 encoded in SJL/J mice contains three amino
acid polymorphisms that alter TMEV-induced cytokine expression
and virus-induced apoptosis in macrophages. It remains to be seen
which of the polymorphisms are required for the effects upon
cytokines and apoptosis.
Materials and methods
Experimental animals, cell line, virus
Female B10.S and SJL/J mice were obtained from Jackson
Laboratories (Bar Harbor, Maine). RAW264.7 cells were originally
obtained from the American Type Culture Collection (Rockville, MD).
The DA strain of TMEV was obtained from Dr. Kristen Drescher,
Department of Medical Microbiology and Immunology, Creighton
University, Omaha, Nebraska. TMEV was grown in BHK-21 cells. The
titer of stock cultures of TMEV was 1×106PFU/ml.
IRF3 cDNA cloning
RNA was isolated from SJL/J and B10.S thioglycollate-elicited
peritoneal macrophages, IRF3 cDNA was ampliﬁed by RT-PCR, cloned
into the pTARGET expression vector, and sequenced. To analyze IL-23
p19 promoter activity, RAW264.7 cells were seeded at 3×105 per well
of a 6-well plate in DMEM cell culture medium containing 10% fetal
bovine serum and 50 μg/ml gentamycin and transfected using lipofec-
tamine with p19prompGL3 promoter reporter vector (Petro, 2005b)
plus pRL renilla luciferase normalization reporter vector plus pCIneo
(empty vector), SJLIRF3pTARGET or B10SIRF3pTARGET. After 24 h 106PFU
of TMEV(DA strain)were added. After an additional 24 h, luciferasewas
measure using the dual reporter luciferase kit of Promega.
Measurement of IFNβ, IL-6, ISG56, and TMEV RNA
RAW264.7 cells were nucleofected with pCIneo(empty vector),
SJLIRF3pTARGET or B10SIRF3pTARGET using an Amaxa nucleofector kit
and then seeded at 3×105 cells per well of a 6 well plate. To evaluate
transfection efﬁcienciesGFPpositive cellswere evaluatedmicroscopically
following parallel nucleofections with pmaxGFP vector (Amaxa), which
constitutively expresses GFP. After 48 h, cells were left untreated
(control) or challenged with TMEV or stimulated with 50 μg/ml
polyinosine-polycytidylic acid (polyIC) (InvivoGen) an agonist of TLR-3
but not RIG-I when polyIC is not transfected into the cytoplasm (Al-
Salleeh and Petro, 2007; Diebold et al., 2003; Yoneyama et al., 2005).
RNA was collected at 9 h for qRT-PCR using the RNAeasy kit of Qiagen
(Valencia, CA). The primer pairs of genes of interest were: IFNβ sense
5′ ATGAACAACA GGTGGATCCTCC 3′ and anti-sense 5′ AGGAGCTCCT
GACATTTCCGAA 3′; IL-6 sense 5′ ATGAAGTTCCTCTCTGCAAGAGACT
3′ and antisense 5′ CACTAGGTTTGC CGAGTAGATCTC 3′, ISG56 sense
5′ CAGAAGCAC ACATTGAAGAAGC 3′ and antisense 5′ TGTAAGTAGCCA-
GAGGAAGGTG 3′; TMEV sense 5′ CTTCCCATTC TACTGCAATG 3′ and
antisense 5′ GTGTTCCTGG TTTACAGTAG3′; and GAPDH sense 5′-
TTGTCAGCAA TGCATCCTGCAC-3′ and antisense 5′-ACAGCTTTCCA-
GAGGGGC CATC-3′. Quantitative PCR reactions were run on an ABI
Prism7000 thermal cycler at 50 °C for2 min, 95 °C for10 min, 45 cycles of
95 °C for 15 s/60 °C for 30 s. Relative levels of mRNA for each factor were
normalized to GAPDH determined by using the Ct value and the formula:
2ΔΔCt.Measurement of apoptosis
RAW264.7 cells were nucleofected with pCIneo(empty vector),
SJLIRF3pTARGET or B10SIRF3pTARGET using an Amaxa Nucleofector Kit V
and then seeded at 6×104 cells perwell of a 96well plate. After 48 h, cells
were left untreated (control) or challenged with TMEV. Activation of
caspase was measured after 16 and 35 h using the Promega Apo-Tox-
Glow assay which measures intracellular caspase 3/7 activity by
quantifying release of luciferin from a luciferin- (Z-DEVD)-tetrapeptide
product and measuring luminescence activity after adding UltraGlo™
luciferase.
PAGE and western blot analysis of IRF-3 and Bax
Ten μg of protein from cell lysates of RAWcells expressing SJL-IRF3 or
B10S-IRF3with orwithout challengewith TMEVwere added to a sample
buffer containing 63 mMTris–HCl, 10% glycerol, 2% SDS, 2.5% 2-ME, and
0.0025% bromophenol blue. Protein concentrations in lysates were
determinedusing theBioRad (Hercules, CA)DCprotein assaykit. Twenty
μl of each sample containing 10 μg of proteinwas run on a 10% SDS, Tris-
glycine-polyacrylamide gel and transferred to a nitrocellulose mem-
brane as previously described (Dahlberg et al., 2006). The membrane
was treated with blocking buffer for 1 h at room temperature, followed
by incubation in 1:1000 dilution of rabbit IgG anti-IRF-3 (Invitrogen),
mouse anti-IgG anti-Bax (Invitrogen), or 1:500 mouse anti-tubulin E7
(Developmental Studies Hybridoma Bank, University of Iowa, Depart-
ment of Biological Sciences, Iowa City, IA) and then 1:1000 dilution of
IRDye® 800CWGoat Anti-Rabbit IgG (Rockland Immunochemicals, Inc.,
Gilbertsville, PA) or Alexa Fluor680-labeled anti-Mouse IgG (Rockland
Immunochemicals). The membrane was washed three times and then
scanned with a LICOR Odyssey® Infrared Imaging System and
densitometry of individual bands was done with the LICOR imaging
software.
Statistical analysis
All datawere analyzed by the Student's t test or theWilcoxon–Mann–
Whitney rank-sum U test to determine the signiﬁcance of differences
between the samplemeans ormedians, respectively. P values of less than
0.05 were considered to be signiﬁcant.
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